M

    Microbot Medical Inc (MBOT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $1.49
    +0.01 (+0.68%)

    Market Cap: $99.39M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(22/36)
    Avg Surprise
    +2.07%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.08 - $-0.06
    3 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.08-9.1%
    60d ago$-0.08-9.1%
    30d ago$-0.08-9.1%
    7d ago$-0.08-9.1%
    Current$-0.07
    Revenue Consensus
    $1M
    Range$1M - $1M
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.09
    Range$-0.12 - $-0.07
    3 analysts
    Revenue Consensus
    $-501330
    Range$-1104000 - $400000
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.09---
    Sep 26EST
    		-$-0.07---
    Jun 26
    		$-0.08$-0.08+0.00%Beat+20.0%
    Mar 26
    		$-0.05$-0.08+37.50%Beat+37.5%
    Dec 25
    		$-0.04$-0.06+33.33%Beat+80.0%
    Sep 25
    		$-0.07$-0.06-16.67%Miss+65.0%
    Jun 25
    		$-0.10$-0.08-25.00%Miss+41.2%
    Mar 25
    		$-0.08$-0.13+38.46%Beat+52.9%
    Dec 24
    		$-0.20$-0.18-11.11%Miss+23.1%
    Sep 24
    		$-0.20$-0.17-17.65%Miss+4.8%
    Jun 24
    		$-0.17$-0.17+0.00%Beat+32.0%
    Mar 24
    		$-0.17$-0.17+0.00%Beat+52.8%
    Dec 23
    		$-0.26$-0.25-4.00%Miss+31.6%
    Sep 23
    		$-0.21$-0.25+16.00%Beat+57.1%
    Jun 23
    		$-0.25$-0.31+19.35%Beat+49.0%
    Mar 23
    		$-0.36$-0.45+20.00%Beat+20.0%
    Dec 22
    		$-0.38$-0.47+19.15%Beat+29.6%
    Sep 22
    		$-0.49$-0.51+3.92%Beat-36.1%
    Jun 22
    		$-0.49$-0.45-8.89%Miss-40.0%
    Mar 22
    		$-0.45$-0.42-7.14%Miss-32.4%
    Dec 21
    		$-0.54$-0.37-45.95%Miss-45.9%
    Sep 21
    		$-0.36$-0.36+0.00%Beat-2.9%
    Jun 21
    		$-0.35$-0.35+0.00%Beat-34.6%
    Mar 21
    		$-0.34$-0.33-3.03%Miss-9.7%
    Dec 20
    		$-0.37$-0.34-8.82%Miss-12.1%
    Sep 20
    		$-0.35$-0.28-25.00%Miss+20.5%
    Jun 20
    		$-0.26$-0.27+3.70%Beat+27.8%
    Mar 20
    		$-0.31$-0.28-10.71%Miss+35.4%
    Dec 19
    		$-0.33$-0.33+0.00%Beat+54.2%
    Sep 19
    		$-0.44$-0.44+0.00%Beat+24.1%
    Jun 19
    		$-0.36$-0.45+20.00%Beat+40.0%
    Mar 19
    		$-0.48$-0.42-14.29%Miss-6.7%
    Dec 18
    		$-0.72$-0.59-22.03%Miss-2300.0%
    Sep 18
    		$-0.58$-0.60+3.33%Beat-28.9%
    Jun 18
    		$-0.60$-0.60+0.00%Beat-566.7%
    Mar 18
    		$-0.45$-0.60+25.00%Beat+25.0%
    Dec 17
    		$-0.03$-0.04+25.00%Beat+99.9%
    Sep 17
    		$-0.45N/AN/ABeat-
    Jun 17
    		$-0.09N/AN/ABeat-
    Mar 17
    		$-0.60$0.00N/ABeat-
    Sep 16
    		$-59.40$-85.05+30.16%Beat-

    Key Metrics

    Valuation
    P/E Ratio-6.21EV/EBITDA-0.89x
    Price/FCF-5.58xFCF Yield-17.92%
    Profitability
    Profit Margin0.00%Operating Margin-2568.00%
    ROE-32.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio18.56xQuick Ratio17.82x
    Trading Statistics
    Beta1.05Avg Volume798.93K
    52-Week High$4.6752-Week Low$1.44

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.50
    SMA 20$1.62
    SMA 50$1.74
    SMA 200$2.05
    EMA 10$1.52
    EMA 20$1.58
    EMA 50$1.71
    EMA 200$2.02

    MACD

    Line: -0.08Signal: -0.08Hist: -0.00

    ADX

    ADX: 26.4+DI: 14.0-DI: 26.4

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down64.0
    PSAR$1.71

    Bollinger Bands

    Upper Band$1.94
    Lower Band$1.30
    %B Position3955%(Upper)
    Band Width0.29

    RSI (14-Day)

    Neutral
    38.2

    Momentum Oscillators

    Stoch %K11.8
    Stoch %D12.1
    Williams %R-84.1
    ROC (10d)-1.3%
    Momentum-0.02
    CCI (20d)-67.9
    MFI (14d)17.6

    Volatility Measures

    ATR (14d)$0.08(5.4%)
    StdDev (20d)0.16
    Hist Vol69.0%(High)

    Volume Flow

    VWAP$1.48
    OBV86.2M
    AD Line-44.8M
    CMF (20d)-0.241

    Volume Metrics

    Avg Vol (20d)820.0K
    Vol Ratio0.5x(Low)
    VWMA (20d)$1.60

    Pivot Points

    R3$1.56
    R2$1.53
    R1$1.51
    Pivot Point$1.48
    S1$1.46
    S2$1.43
    S3$1.41

    Advanced Oscillators

    TSI-23.18
    Ultimate Osc39.7
    KST-156.45

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$241,000$105,000$0$0$0$0$84,000$0$0$0$142,000$0
    Cost of Revenue$884,000$103,000$10,000$0$0$0$26,000$0$0$0$35,000$0
    Gross Profit$-643,000$2,000$-10,000$0$0$0$-26,000$0$0$0$-35,000$0
    Operating Expenses$5.54M$4.32M$4.14M$3.86M$3.72M$3.02M$3.43M$3.30M$2.51M$2.38M$2.07M$2.54M
    R&D$1.86M$1.29M$1.54M$1.17M$2.11M$1.46M$1.98M$2.06M$1.42M$1.17M$1.13M$1.61M
    SG&A$3.68M$3.03M$2.60M$2.69M$1.61M$1.56M$1.45M$1.24M$1.09M$1.22M$938,000$932,000
    Operating Income$-6,188,000$-4,320,000$-4,138,000$-3,861,000$-3,723,000$-3,021,000$-3,430,000$-3,300,000$-2,511,000$-2,384,000$-2,068,000$-2,544,000
    Interest Income$561,000$649,000$674,000$284,000$223,000$104,000$38,000$85,000$46,000$13,000$27,000$98,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$1.08M$0
    Income Before Tax$-5,627,000$-3,671,000$-3,464,000$-3,577,000$-3,500,000$-2,601,000$-3,392,000$-3,215,000$-2,465,000$-2,371,000$-3,152,000$-2,446,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,627,000$-3,671,000$-3,464,000$-3,577,000$-3,500,000$-2,601,000$-3,392,000$-3,215,000$-2,465,000$-2,371,000$-3,154,000$-2,446,000
    EBITDA$-6,173,000$-4,308,000$-4,128,000$-3,851,000$-3,711,000$-2,690,000$-3,404,000$-3,277,000$-2,497,000$-2,356,000$-2,033,000$-2,524,000
    EBIT$-6,188,000$-4,320,000$-4,138,000$-3,861,000$-3,723,000$-2,705,000$-3,430,000$-3,300,000$-2,511,000$-2,384,000$-2,068,000$-2,544,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MBOT

    News

    HC Wainwright Lowers Earnings Estimates for Microbot Medical

    HC Wainwright has revised its Q3 and full-year 2026 earnings estimates for Microbot Medical (NASDAQ:MBOT), lowering the Q3 EPS estimate to a loss of $0.08 per share from $0.06, while maintaining a "Buy" rating. The full-year 2026 estimate is now a loss of $0.29 per share. Despite mixed analyst sentiment, Microbot Medical recently reported a quarterly loss of $0.08 per share, in line with consensus, and revenue of $0.24 million, surpassing expectations.

    MarketBeat•8/21/26•
    Neutral

    H.C. Wainwright reiterates Microbot Medical stock rating on revenue growth

    H.C. Wainwright has reiterated a Buy rating and a $12.00 price target for Microbot Medical (NASDAQ:MBOT) following strong second-quarter 2026 financial results, which saw revenue exceed analyst projections and grow over 100% quarter-over-quarter. Despite a net loss, the company's LIBERTY System has seen increased adoption and expanded sales territories, with plans for further expansion and manufacturing capacity. Microbot Medical also announced a manufacturing partnership with Sanmina Corporation and an amendment to their CFO's employment agreement.

    Investing.com•8/19/26•
    Somewhat-Bullish

    B. Riley Financial Reaffirms "Buy" Rating for Microbot Medical (NASDAQ:MBOT)

    B. Riley Financial has reaffirmed its "Buy" rating for Microbot Medical (NASDAQ:MBOT) but reduced its price target from $5.00 to $4.00, still implying a significant upside of 146%. Despite a positive overall "Moderate Buy" consensus from analysts, the stock is currently near its one-year low. Microbot Medical met EPS estimates and exceeded revenue expectations in its latest quarterly report, with institutional investors holding 16.3% of the company.

    MarketBeat•8/14/26•
    Somewhat-Bullish

    Microbot Medical Q2 revenue jumps 100% QoQ

    Microbot Medical Inc. announced a 100% quarter-over-quarter revenue and customer growth for Q2 2026, driven by the successful Full Market Release of its LIBERTY System. The company expanded its market presence in the U.S., secured a federal healthcare agreement, and achieved international marketing clearance in Israel, alongside plans to increase manufacturing capacity. These strategic moves and cost reduction initiatives are expected to further boost financial performance.

    Medical Buyer•8/12/26•
    Bullish

    Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

    Microbot Medical Inc. (NASDAQ: MBOT) announced significant revenue and customer growth in its Q2 2026 10-Q filing, with revenue increasing over 100% due to expanded utilization and new customer acquisitions since its Full Market Release in April 2026. The company expanded its market footprint, added new health systems, and received regulatory clearance in Israel for its LIBERTY® Endovascular Robotic System. Microbot Medical is also establishing a second manufacturing site to meet anticipated demand and reduce costs.

    GlobeNewswire•8/12/26•
    Bullish

    Frequently Asked Questions About MBOT

    Does MBOT pay dividends?
    Microbot Medical Inc (MBOT) does not currently pay a regular dividend.
    What is MBOT's market cap?
    Microbot Medical Inc (MBOT) has a market capitalization of $99.39M with a current stock price of $1.49.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In